AAPG Ascentage Pharma Corp Gross Return on Sales

Official company branding of Ascentage Pharma Group International (AAPG)

Ascentage Pharma Group leads the development of targeted oncology, leveraging the success of its leukemia drugs and its partnership with Takeda. Scaling sales in China is creating a financial foundation, which is partially offset by R&D expenses. Growth is driven by the approval of new therapies and investments. The current gross margin, as shown on this GURU.Markets chart, expresses the latest metric level via 83.20.

Ascentage Pharma Group (AAPG) - Gross Margin from 01/25/2025 to 11/19/2026

Financial and market metric breakdowns for Ascentage Pharma Group International (AAPG)

Original product of Ascentage Pharma

For a comparative analysis of asset efficiency, it is critical for an investor to evaluate gross margin as the difference between revenue and direct cost of goods sold, which determines a business's ability to generate profit. In Ascentage Pharma Group (AAPG), this metric reflects the cost of developing oncology drugs while accounting for strict medical regulations regarding biomaterial disposal, allowing investors to monitor the company's financial stability via the current gross margin level on GURU.Markets.

Main competitors

Gross Profit Margin BeiGene Ltd. (ONC)|Return on Gross Profit HALO|Gross Profitability RVMD|Gross Margin CGON|UroGen Pharma - Gross Return on Sales|Bicara Therapeutics - Return on Gross Profit|Gross Margin Personalis Inc PSNL|Erasca Oncology - Gross Margin|Gross Profit Rate DCTH (Delcath Corp)|YMAB: Gross Margin|AURA - Return on Sales by Gross Profit|CADL (Candel Therapeutics Inc.) - Gross Margin|Gross Return on Sales ARAY (Accuray)|Return on Gross Profit SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Gross Profit Margin|Gross Profitability Citius Oncology, Inc. CTOR|HURA - Return on Gross Profit|protaratx.com - Gross Margin|FATE - Gross Margin|WHWK: Gross Margin|TScan Therapeutics (TCRX) - Gross Margin|Gross Profitability Champions Oncology|Gross Profitability XBIT|Gross Margin CVM|Return on Gross Profit OS Therapies Inc. OSTX|Gross Profitability Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Gross Profit Margin|ANL - Gross Profitability|Gross Profit Margin verupharma.com|TPST: Gross Margin|XLO - Return on Sales by Gross Profit|Gross Profitability Renovaro|Gross Margin muraloncology.com|Gross Margin KAPA|Return on Sales by Gross Profit OnKure Therapeutics, Inc.|Gross Margin GDTC (w2.cytomed.sg)|CRIS - Return on Gross Profit|Apollomics - Gross Margin|Tharimmune Corp (THAR) - Return on Gross Profit|ADVB: Gross Margin|Return on Gross Profit Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Gross Margin|Gross Return on Sales SBFM (Sunshine Biopharma)|Gross Profitability Xenetic Bio (XBIO)|Gross Profitability SLRX (Salarius Pharma)|Kitov Pharma - Return on Gross Profit|American Oncology Network (AONC) - Gross Profit Margin|BeiGene - Gross Margin|Checkpoint Therapeutics, Inc. (CKPT) - Return on Gross Profit|ELEV (Elevation Oncology, Inc.) - Return on Gross Profit|iCAD Inc. - Gross Profit Rate|Return on Gross Profit IKNA|Gross Margin notablelabs.com|Return on Gross Profit VIRX (Viracta Therapeutics Inc.)|MOR - Gross Profit Margin|Gross Profitability NAYA Biosciences NAYA|AAPGV - Return on Gross Profit